According to reports, some senior Biden administration officials realized two weeks ago that there were problems with Johnson & Johnson’s contractors, which could cause delays in a large number of vaccines.
According to reports on Wednesday, workers at the Emergent BioSolutions plant in Baltimore mixed ingredients from a single dose of Johnson & Johnson’s vaccine with ingredients from another dose, destroying 15 million doses.
Since then, future shipments of the vaccine have ceased.
However, according to the “Pooliday” report, two senior officials engaged in the COVID-19 response work said that the problem of the emergency production plant was clarified earlier this month.
A third official told the media that the Ministry of Health and Human Services found an error in the emergency situation last week.
The official said: “As we all know, Emergent does not have strong pharmaceutical experts.”
Two officials of the company told Politico that the company’s failure would delay the future shipment of Johnson & Johnson vaccines, and the distribution of vaccines to states would slow down in the next few weeks.
An official said that Johnson & Johnson will still be able to achieve the goals set out in the contract signed with the federal government.
Johnson & Johnson had promised to provide the government with 100 million doses of medicine by the end of May, but it barely reached its goal of providing 20 million doses by the end of March.
The US Food and Drug Administration (FDA) is investigating this confusion.